92 related articles for article (PubMed ID: 3664485)
1. A unique tumor rejection antigen from the S91 murine malignant melanoma.
Law LW; Vieira WD; Kameyama K; Hearing VJ
Cancer Res; 1987 Nov; 47(22):5841-5. PubMed ID: 3664485
[TBL] [Abstract][Full Text] [Related]
2. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
[TBL] [Abstract][Full Text] [Related]
3. Serological characterization of a shared melanoma-associated antigen of mouse melanomas: relationship to the B700 glycoprotein.
DeLeo AB; Hearing VJ; Vieira WD; Law LW
Melanoma Res; 1991; 1(2):133-40. PubMed ID: 1668533
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of B700 cross-reactive antigens on human and other animal melanomas.
Gersten DM; Hearing VJ
Pigment Cell Res; 1988; 1(6):434-8. PubMed ID: 3237611
[TBL] [Abstract][Full Text] [Related]
5. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
7. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
8. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
Tan XH; Wan YH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1596-600. PubMed ID: 16185524
[TBL] [Abstract][Full Text] [Related]
9. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes.
Toporowicz A; Gersten DM; Hearing VJ; Brown WE; Vlock DR
Biochim Biophys Acta; 1993 Aug; 1182(1):51-6. PubMed ID: 7688577
[TBL] [Abstract][Full Text] [Related]
11. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy.
Shrayer DP; Bogaars H; Hearing VJ; Wanebo HJ
J Exp Ther Oncol; 1996 Mar; 1(2):126-33. PubMed ID: 9414396
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties.
Gersten DM; Moody D; Vieira WD; Law LW; Hearing VJ
Biochim Biophys Acta; 1992 Feb; 1138(2):109-14. PubMed ID: 1540656
[TBL] [Abstract][Full Text] [Related]
13. Partial purification of C-C36 tumor rejection antigen molecules commonly expressed on syngeneic murine colon tumors, C-C36 and C-C26.
Sato N; Sato T; Takahashi S; Fujimoto N; Koshiba H; Ishii Y; Kikuchi K
Jpn J Cancer Res; 1986 May; 77(5):473-9. PubMed ID: 3089978
[TBL] [Abstract][Full Text] [Related]
14. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma: cross-reacting (common) tumor rejection antigens.
Hearing VJ; Vieira WD; Law LW
Int J Cancer; 1985 Mar; 35(3):403-9. PubMed ID: 2579039
[TBL] [Abstract][Full Text] [Related]
17. Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment.
Yang Y; Yang S; Ye Z; Jaffar J; Zhou Y; Cutter E; Lieber A; Hellström I; Hellström KE
Cancer Res; 2007 Mar; 67(5):2339-44. PubMed ID: 17332366
[TBL] [Abstract][Full Text] [Related]
18. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
Sato N; Kikuchi K
J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of immunogenicity with the poorly immunogenic B16 melanoma.
Celik C; Lewis DA; Goldrosen MH
Cancer Res; 1983 Aug; 43(8):3507-10. PubMed ID: 6861123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
